Aakaar Medical Technologies Limited is a medical technology company focused on distributing medical equipment, cosmetics, and healthcare products, incorporated under the Companies Act 1956.
Listed on the NSE EMERGE platform in June 2025, with operations spanning injectables, botulinum toxin, regenerative products (exosomes), and hair care solutions.
Promoter Dilip Meswani, with 25 years in the aesthetic and dermatology industry, leads the company's strategic expansion into medical aesthetics and skincare.
Core operations include medical devices (dermal fillers, botulinum toxin), cosmetics, and non-prescribed drugs.
Expanded into regenerative therapies (exosomes), hair care (DRS1512, Tubelite GFC), and psoriasis treatments via partnerships.
Diversified into medical aesthetics (injectables, chemical peels) and dermatology solutions, with a focus on USFDA-approved products like Letybo and Saypha.
Research report
companyname: Aakaar Medical Technologies Limited
ticker: AAKAAR
sector: Medical Aesthetics / Cosmetic Dermatology
Aakaar Medical Technologies is a doctor-focused medical aesthetics company operating through B2B channels. It supplies dermatologists, plastic surgeons, aesthetic physicians and clinics across India with aesthetic products and medical devices, and those clinicians sell the products to patients or use device consumables in treatments. Incorporated on June 20, 2013, it became the firs...
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Aakaar Medical and 4,900+ companies.